Jonathan Sharrett, DO
Radiation Oncology · Post Falls, IDNPI 1275910960
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations.
Across 30 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$163
- Novartis$106
- Merck$92
- Stemline Therapeutics Inc.$52
- Pfizer$47
- Regeneron Healthcare Solutions, Inc.$29
- plus $266 from 13 others
What the payments were for
- Food & beverage$755100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 3 | $163 |
| Novartis | 5 | $106 |
| Merck | 4 | $92 |
| Stemline Therapeutics Inc. | 2 | $52 |
| Pfizer | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| EUSA Pharma (US) LLC | 1 | $27 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| GSK | 1 | $22 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Amgen | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Novocure Inc. | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADCETRIS$123
How this compares
$755 in reported general payments places this provider in the 55th percentile of 22 radiation oncology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Solifenacin Succinate | 11 | $613 |
| Tamsulosin Hcl | 32 | $292 |
| Dexamethasone | 21 | $240 |
| Gabapentin | 12 | $112 |
| Omeprazole | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Post Falls
- Corbin JacobsPost Falls$806
- Gary van HeuvelenPost Falls$0
- Calvin McAllisterIdaho Falls$6K
- Daniel MillerIdaho Falls$6K
- Norman WillisLewiston$5K
- Jennifer RobinsonPocatello$4K
- Steven ToddPocatello$2K
- David KoeplinBoise$2K
- Michael CallaghanPocatello$2K
- Calvin RockPocatello$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.